S Ambretti
Overview
Explore the profile of S Ambretti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foschi C, Lombardo D, Gaibani P, Re M, Ambretti S
J Hosp Infect
. 2020 Oct;
108:221-223.
PMID: 33127457
No abstract available.
2.
Zaghi I, Gaibani P, Campoli C, Bartoletti M, Giannella M, Ambretti S, et al.
Clin Microbiol Infect
. 2020 May;
26(10):1338-1344.
PMID: 32376295
Background: Serum bactericidal titres (SBTs) were widely used in the 1970s and 1980s to monitor antimicrobial therapy but are now seldom recommended. It is the only laboratory test that integrates...
3.
Bartoletti M, Rinaldi M, Pasquini Z, Scudeller L, Piano S, Giacobbe D, et al.
Clin Microbiol Infect
. 2020 May;
27(2):276-282.
PMID: 32360775
Objectives: The aim of this study was to evaluate the risk factors for candidaemia in patients with liver cirrhosis. Methods: This was a case-control-control (1:2:2) study performed in four Italian...
4.
Giannella M, Pascale R, Pancaldi L, Monari C, Ianniruberto S, Malosso P, et al.
Clin Microbiol Infect
. 2020 Feb;
26(7):897-903.
PMID: 32006697
Objectives: We examined factors associated with follow-up blood cultures (FUBCs) in patients with monomicrobial Gram-negative (GN) bloodstream infection (BSI) and investigated the impact of FUBCs on therapeutic management and patient...
5.
Gaibani P, Re M, Campoli C, Viale P, Ambretti S
Clin Microbiol Infect
. 2019 Nov;
26(4):516.e1-516.e4.
PMID: 31740422
Objectives: The aim of this study was to evaluate the incidence of ceftazidime/avibactam resistance among Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-Kp) strains isolated from patients with bloodstream infection. Methods:...
6.
Cordovana M, Deni A, Kostrzewa M, Abdalla M, Ambretti S
New Microbes New Infect
. 2019 Jun;
30:100546.
PMID: 31193023
is a fastidious, pink-pigmented, obligate aerobic Gram-negative bacillus commonly isolated from various environmental sources, and only occasionally from clinical samples, mostly in immunocompromised patients or associated with intravascular devices and...
7.
Giannella M, Bartoletti M, Campoli C, Rinaldi M, Coladonato S, Pascale R, et al.
Clin Microbiol Infect
. 2019 May;
25(12):1525-1531.
PMID: 31039445
Objective: To investigate the impact of colonization with carbapenemase-producing Enterobacteriaceae (CPE) on the CPE infection risk after liver transplantation (LT). Methods: Prospective cohort study of all adult patients undergoing LT...
8.
Errico G, Gagliotti C, Monaco M, Masiero L, Gaibani P, Ambretti S, et al.
Clin Microbiol Infect
. 2018 May;
25(2):203-209.
PMID: 29800674
Objectives: A prospective cohort study was conducted in Italy in order to describe the microbiologic aspects of colonization/infection by carbapenemase-producing Enterobacteriaceae (CPE) in donors and recipients of lung and liver...
9.
Cordovana M, Kostrzewa M, Soki J, Witt E, Ambretti S, Pranada A
Anaerobe
. 2018 Apr;
54:246-253.
PMID: 29626622
Bacteroides fragilis is a frequent anaerobic pathogen and can cause severe infections. Resistance to carbapenems, associated with the cfiA gene encoded carbapenemase, represents an emerging problem. To date, no rapid...
10.
Giannella M, Pascale R, Toschi A, Ferraro G, Graziano E, Furii F, et al.
Clin Microbiol Infect
. 2018 Jan;
24(10):1077-1083.
PMID: 29371138
Objectives: To investigate the impact of treatment duration on mortality and on relapse in patients with Escherichia coli bloodstream infection (BSI). Methods: Retrospective single-centre study of patients diagnosed with E. ...